AKT1 and hepatocellular carcinoma: The results indicated that in HCC cells, RFX5 knockdown could suppress the expression of proteins that participated in the glycolysis metabolism pathway (HK2 and LDHA), p‐AKT, and β‐catenin, and additional STIL overexpression could counteract the inhibitory effect (Figure 5G).